New FDA-Approved Therapy Brings At-Home Electrical Field Treatment to Pancreatic Cancer Care
The wearable system uses alternating electrical fields to disrupt cancer cell division and can be used continuously during daily activities.
The wearable system uses alternating electrical fields to disrupt cancer cell division and can be used continuously during daily activities.
The FDA now mandates that medical device manufacturers include a Software Bill of Materials for cybersecurity compliance under the FD&C Act.
The wearable system uses alternating electrical fields to disrupt cancer cell division and can be used continuously during daily activities.